Lorbrena 63539-0927-01
Generic: Lorlatinib
- Manufacturer
- U.s. Pharmaceuticals
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 3, 2023
- Listing Expires
- December 31, 2027
- Application
- NDA210868
Need to source Lorbrena? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lorlatinib | 25 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]Cytochrome P450 2B6 Inducers [MoA]
Selected Package
63539-0927-01Selected30 TABLET, FILM COATED in 1 BOTTLE (63539-927-01)